Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylene plus pantoprazole versus pantoprazole alone for gastro-esophageal reflux symptoms
IRCT20180422039378N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of pantoprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoint: Gastro-esophageal reflux. Started Apr 2017; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on IRCT20180422039378N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180422039378N1.